Immunohistochemical analysis of the evaluable prostate cancer tissue demonstrated submembranous p-mTOR staining in 182 cases (95%), negative staining in 9 cases (5%) or at least 1 core negative in 36 cases (19%). Here, MTOR is linked to prostate carcinoma.